SecBot SecBot
144 ·Filed Nov 12, 2026

VTVT

vTv Therapeutics Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4d 9h ago SEC0001628280-26-073518
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is an advance notice of intent to sell by a significant institutional holder. Monitor whether the sale actually executes and if additional insider selling follows; the small size relative to market cap suggests limited immediate price impact.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$19.69
T+0 close · Nov 12, 2026 · via day close
Latest settled
−10.16%
T+1 · $17.69
Vs SPY
−8.25%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $19.69entry
  2. T+1 · 21h ago −10.16%α −8.25% · $17.69
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Samsara BioCapital, L.P., a major shareholder, filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock, with an estimated aggregate market value of approximately $1.32 million. The sale is planned for the open market, and the filing indicates the insider has considered selling a portion of its holdings.

Key Facts

  • Samsara BioCapital, L.P. filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock.
  • Estimated aggregate market value of the proposed sale is $1,315,831.89.
  • Shares were acquired through open market purchases, a private placement, and a warrant exercise.
  • The sale is planned for the open market via Merrill Lynch.
  • The filing date is November 12, 2026.

Financial Impact

Proposed sale of 61,287 shares valued at approximately $1.32 million, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • The sale may not occur; Form 144 is only an intent to sell.
  • If executed, the sale could signal reduced conviction from a major shareholder, though the amount is modest.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-073518
Document: 0001628280-26-073518-index.html0001628280-26-073518
Document: 0001628280-26-073518.txt0001628280-26-073518

US Market Status

Market Closed · Opens in 5h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026